Product: Eviti Connect

Filter

Thought Leadership

Product

Community

Eviti Connect Infographic
For payers, Eviti Connect streamlines the authorization of cancer treatment, ensuring prescription of high-quality, high-value care and setting patients on...
Eviti Connect
Eviti Webinar Recording: A Look Ahead—The Pandemic’s Impact on Payers
Over the past few months, we’ve seen a fundamental shift in healthcare. With this change comes a host of uncertainty...
Eviti Connect
Safety Check: What Providers can Learn from Pilots
As an Air Force pilot, the jets I flew all came with User’s Manuals, but unlike the one in your...
Eviti Connect
Eviti Webinar Recording: Oncology Treatment Validation—What is it and Why is it Important?
Spending on cancer drugs in the United States has now exceeded $56 billion and the median annual cost of a new cancer...
Eviti Connect
Eviti Connect
NantHealth’s Cancer Therapy Pre-Authorization Platform Eviti Connect® Starts 2020 Strong with Two Expanded Programs
Continued Relationships with Health Insurers Reflect the Need for High-quality, High-value Care as Cancer Treatments Become Increasingly Complex Culver City,...
Eviti Connect
Eviti Connect
NantHealth’s Eviti Connect Data Shows Recycling of Chemotherapy and Biologics for Advanced CRC Patients More Common Than Switching to Drug...
NantHealth Presented These Findings at the ASCO 2020 Gastrointestinal Cancers Symposium San Francisco, CA – January 25, 2020: NantHealth, Inc....
Eviti Connect
Eviti Connect
The Evolution of Value-Based Care: A Shift to Patient-Centric Care
Learn how payers can curb out-of-control cancer costs and address the inevitable swing to consumer-driven approaches to care. This webcast...
Eviti Connect
Eviti Connect
Panel Discussion: Technology’s Role in Reducing Rising Cancer Care Costs
Innovative new treatments and advanced therapies have provided a fundamental shift in oncology care. This evolution has transformed outcomes for...
Eviti Connect
Eviti Connect
Biosimilars: Fact vs Fiction—Understanding biosimilars and their potential for lowering cancer care costs
Biosimilars are becoming quite the buzzword in cancer treatment, but cost, regulation, safety and efficacy are driving questions amongst payers...
Eviti Connect
Eviti Connect Brochure
Cancer care is costly and complex; and if you don’t have the tools needed to effectively manage your cancer spend,...
Eviti Connect